Maiko Ono

Title: Maiko Ono: Innovator in α-Synuclein Aggregate Binding

Introduction

Maiko Ono is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target α-synuclein aggregates. His work is crucial for advancing treatments for neurodegenerative diseases.

Latest Patents

Maiko Ono holds 1 patent for a compound that acts as an α-synuclein aggregate binder. This invention is represented by specific chemical formulas and includes pharmaceutically acceptable salts or solvates. The implications of this patent are significant for therapeutic applications in treating conditions associated with α-synuclein aggregation.

Career Highlights

Throughout his career, Maiko Ono has worked with esteemed organizations such as the National Institutes for Quantum Science and Technology and Eisai R&D Management Co., Ltd. His experience in these institutions has allowed him to collaborate on innovative research projects that push the boundaries of current scientific understanding.

Collaborations

Maiko has collaborated with notable colleagues, including Makoto Higuchi and Meiei Cho. These partnerships have fostered a productive environment for research and development in their respective fields.

Conclusion

Maiko Ono's contributions to the field of pharmaceuticals, particularly through his patent on α-synuclein aggregate binders, highlight his role as an innovator. His work continues to pave the way for advancements in treating neurodegenerative diseases.